Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dynavax, Generex rocket as drug stocks dip
Marketwatch
Thursday, September 10, 2009 - 10:43am
tags:
Dynavax, Generex, drug stocks
Vical's swine flu vaccine works in mice, rabbits
Yahoo/AP
Thursday, September 10, 2009 - 10:38am
tags:
Vical, swine flu, vaccines, H1N1
Vivus's Qnexa Drug Approval Makes It a Nice Trade
Seeking Alpha
Thursday, September 10, 2009 - 10:36am
tags:
Vivus, obesity, Qnexa
Study weakens Lilly's fight against price controls
Indianapolis Business Journal, IN
Thursday, September 10, 2009 - 10:32am
tags:
price controls, Eli Lilly, healthcare reform
Judge To Give Jury 'Cooling Off' Period In Fosamax Case
NASDAQ.com
Thursday, September 10, 2009 - 10:30am
tags:
Fosamax, osteoporosis, lawsuits, Merck
Merck reports mixed data for migraine drug
Marketwatch
Thursday, September 10, 2009 - 8:59am
tags:
Merck, migraines
Report: Large Majorities of Public Blame Health Insurers, Drug Industry, Republicans, Business for Problems with Our Current Health Care
Fierce Biotech
Thursday, September 10, 2009 - 8:53am
tags:
drug industry, healthcare reform
Biogen Maintains Facet Offer
Yahoo/Zacks.com
Thursday, September 10, 2009 - 8:52am
tags:
Biogen Idec, Facet Biotech, M&A, Acorda Therapeutics, Bristol-Myers Squibb
FDA panel backs Gardasil for use by men
Yahoo/AP
Thursday, September 10, 2009 - 8:51am
tags:
FDA, Gardasil, Merck, vaccines, HPV
Onyx’s Nexavar Helps Breast Cancer Patients, CEO Says
Bloomberg
Thursday, September 10, 2009 - 8:50am
tags:
ONYX Pharmaceuticals, Nexavar, breast cancer
GlaxoSmithKline cut at SocGen on threat to Advair
Marketwatch
Thursday, September 10, 2009 - 8:48am
tags:
GSK, Advair, downgrades, generics
Good News for Salix
Yahoo/Zacks.com
Wednesday, September 9, 2009 - 3:46pm
tags:
Salix, AstraZeneca, Metozolv, JNJ
What the Baucus Bill Could Mean for Chantix
WSJ Online
Wednesday, September 9, 2009 - 3:16pm
tags:
healthcare reform, Chantix, Pfizer, smoking cessation
Disappointment for Osiris
Yahoo/Zacks.com
Wednesday, September 9, 2009 - 3:15pm
tags:
Osiris Therapeutics, Prochymal
Targeted Genetics sells assets to Genzyme
Yahoo/AP
Wednesday, September 9, 2009 - 3:14pm
tags:
Targeted Genetics, Genzyme
FDA panel backs Glaxo's cervical vaccine for women
Yahoo/AP
Wednesday, September 9, 2009 - 3:11pm
tags:
GSK, Cervarix, FDA, vaccines, HPV
Sepracor shareholders sue to block deal
Fierce Pharma
Wednesday, September 9, 2009 - 10:45am
tags:
Sepracor, M&A, Dainippon Sumitomo
Red-hot Novavax negotiating vax tech transfers
Fierce Biotech
Wednesday, September 9, 2009 - 9:37am
tags:
Novavax, vaccines
FDA OKs Ista's itchy eye drug
Forbes/AP
Wednesday, September 9, 2009 - 9:35am
tags:
FDA, Ista
[video] One on One with Fred Hassan
CNBC
Wednesday, September 9, 2009 - 9:01am
tags:
Fred Hassan, Schering Plough, Pharma CEOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.